thyroid cancer

March 5, 2026

Thyroid cancer ‘atlas’ points to cell types that contribute to disease progression

A multi-institutional study led by Vanderbilt Health investigators provides a spatial understanding of thyroid cancer evolution and identifies cell types that may predict aggressive disease in both children and adults.

Vivian Weiss, MD, PhD, center, George Xu, left, and Matthew Loberg led a multidisciplinary study that identified a molecular signature for aggressive thyroid cancer, which could help guide treatment approaches for patients. (photo by Susan Urmy)
September 25, 2023

Researchers discover molecular signature for aggressive thyroid cancer

A Vanderbilt study found that a molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients.

January 19, 2023

Pediatric surgeon’s medical career began with a lucky catch

While he was in medical school, pediatric surgeon Joseph Fusco, MD, learned in an unusual way that he had thyroid cancer.

Yike Li, PhD, and Maria Powell, PhD, examine patient Judit Kiss during a follow-up appointment at the Vanderbilt Voice Center.
October 20, 2022

Implanted stimulator used to treat vocal cord paralysis

Vanderbilt is the only place in the world that has an implantable bilateral pacemaker that can stimulate opening of both vocal folds in patients with bilateral vocal fold paralysis, allowing them to both breathe and speak.

December 2, 2021

Thyroid cancer paper lands national recognition

August 26, 2021

Obese children, young adults at higher risk for thyroid cancer

Children and young adults who are obese are at greater risk for malignant thyroid nodules, according to new study from Monroe Carell Jr. Children’s Hospital at Vanderbilt.